Cantor Fitzgerald Research Analysts Raise Earnings Estimates for UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (NYSE:UNH) – Equities research analysts at Cantor Fitzgerald upped their FY2018 earnings estimates for shares of UnitedHealth Group in a research report issued to clients and investors on Wednesday, October 17th. Cantor Fitzgerald analyst S. Halper now anticipates that the healthcare conglomerate will post earnings of $12.80 per share for the year, up from their prior forecast of $12.70. Cantor Fitzgerald has a “Buy” rating and a $300.00 price target on the stock. Cantor Fitzgerald also issued estimates for UnitedHealth Group’s FY2019 earnings at $14.65 EPS.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. The business had revenue of $56.56 billion for the quarter, compared to analysts’ expectations of $56.34 billion. During the same period last year, the company earned $2.66 earnings per share. The company’s quarterly revenue was up 12.4% on a year-over-year basis.

A number of other brokerages have also recently weighed in on UNH. Oppenheimer lifted their price target on shares of UnitedHealth Group from $276.00 to $295.00 and gave the company an “outperform” rating in a research report on Wednesday. Argus lifted their price target on shares of UnitedHealth Group to $285.00 and gave the company a “buy” rating in a research report on Thursday. BMO Capital Markets lifted their price target on shares of UnitedHealth Group to $310.00 and gave the company an “outperform” rating in a research report on Thursday. Royal Bank of Canada lifted their price target on shares of UnitedHealth Group to $308.00 and gave the company an “outperform” rating in a research report on Wednesday. Finally, Piper Jaffray Companies lifted their price target on shares of UnitedHealth Group to $300.00 and gave the company an “overweight” rating in a research report on Wednesday. One investment analyst has rated the stock with a hold rating, twenty-three have given a buy rating and one has issued a strong buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $289.41.

UNH opened at $266.81 on Thursday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.75 and a current ratio of 0.75. UnitedHealth Group has a 1 year low of $202.70 and a 1 year high of $272.81. The company has a market capitalization of $256.06 billion, a P/E ratio of 26.50, a P/E/G ratio of 1.58 and a beta of 0.73.

In other news, CEO Steven H. Nelson sold 26,033 shares of UnitedHealth Group stock in a transaction that occurred on Friday, September 7th. The shares were sold at an average price of $270.65, for a total transaction of $7,045,831.45. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director William C. Ballard, Jr. sold 10,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, August 8th. The shares were sold at an average price of $258.83, for a total transaction of $2,588,300.00. Following the sale, the director now owns 77,172 shares in the company, valued at approximately $19,974,428.76. The disclosure for this sale can be found here. Insiders have sold 94,568 shares of company stock worth $24,950,027 in the last quarter. Insiders own 0.87% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Legacy Advisors LLC raised its stake in shares of UnitedHealth Group by 2,274.7% during the third quarter. Legacy Advisors LLC now owns 6,008 shares of the healthcare conglomerate’s stock valued at $1,598,000 after purchasing an additional 5,755 shares during the period. TIAA FSB increased its stake in shares of UnitedHealth Group by 2.8% in the third quarter. TIAA FSB now owns 157,956 shares of the healthcare conglomerate’s stock worth $42,023,000 after buying an additional 4,280 shares during the last quarter. Empirical Finance LLC increased its stake in shares of UnitedHealth Group by 13.3% in the third quarter. Empirical Finance LLC now owns 1,861 shares of the healthcare conglomerate’s stock worth $495,000 after buying an additional 219 shares during the last quarter. Huntington National Bank increased its stake in shares of UnitedHealth Group by 34.0% in the third quarter. Huntington National Bank now owns 164,411 shares of the healthcare conglomerate’s stock worth $43,740,000 after buying an additional 41,743 shares during the last quarter. Finally, Oakbrook Investments LLC increased its stake in shares of UnitedHealth Group by 0.5% in the third quarter. Oakbrook Investments LLC now owns 46,175 shares of the healthcare conglomerate’s stock worth $12,284,000 after buying an additional 250 shares during the last quarter. Institutional investors own 85.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: How to Profit and Limit Losses With Stop Orders

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply